Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Colorectal Neoplasms peptide trials
2 selected ClinicalTrials.gov records carrying the official condition label Colorectal Neoplasms. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
2 selected records.
2 profiles.
2026–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 55 selected PubMed records and 6 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Colorectal Neoplasms unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT07715903
PeptideScanner retained ClinicalTrials.gov record NCT07715903 at 2026-11-17T13:28:01.467Z. Its registry update date was 2026-11-16, and PeptideScanner's reviewed identity mapping was carfilzomib.
- PeptideScanner change date
- November 17, 2026
- Cited source date
- November 16, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT06024356
PeptideScanner retained ClinicalTrials.gov record NCT06024356 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-06-18, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- June 18, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Carfilzomib · 2026-11-16
ClinicalTrials.gov record NCT07715903
Not yet recruiting at the retained observation.
Open attributed record →Thymosin alpha-1 · 2026-06-18
ClinicalTrials.gov record NCT06024356
Completed at the retained observation.
Open attributed record →